Cyclopentane

Cyclopentane

SCHEMBL4188224

C1CCCC1.CC(C)NCc1ccccc1NS(=O)(=O)c1ccc2c(c1)C(=O)CCO2

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 5/20 0.42
PKM P14618 3/20 0.42
HPGD P15428 5/20 0.41
HSD17B10 Q99714 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
RRM1 P23921 1/20 0.40
RRM2B Q7LG56 1/20 0.40
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
PTGES2 Q9H7Z7 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4204437 0.88 KDM4E (0.43) ALDH1A1KDM4EPKMHPGDHSD17B10
SCHEMBL4188219 0.88 KDM4E (0.43) ALDH1A1KDM4EPKMHPGDHSD17B10
Cyclopentane SCHEMBL4192569 0.76 KDM4E (0.48) ALDH1A1KDM4EPKMHSD17B10SMN1; SMN2
Cyclohexane SCHEMBL4198292 0.74 KMT2A (0.47) ALDH1A1KDM4EPKMSMN1; SMN2POLB
SCHEMBL4474002 0.69 HPGD (0.59) ALDH1A1PKMHPGDHSD17B10SMN1; SMN2
Cyclohexane SCHEMBL4204059 0.69 GAA (0.50) ALDH1A1KDM4EPKMHSD17B10SMN1; SMN2
Cyclopentane SCHEMBL14348246 0.68 TP53 (0.45) ALDH1A1KDM4EPKMPOLBMEN1
Cyclopentane SCHEMBL9986871 0.67 ACLY (0.54) ALDH1A1KDM4EPKMSMN1; SMN2POLB
SCHEMBL4189928 0.67 PKM (0.49) ALDH1A1KDM4EPKMSMN1; SMN2TSHR
Cyclohexane SCHEMBL4193643 0.67 ESR1 (0.46) ALDH1A1PKMPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 ALDH1A1 2744/4885KDM4E 3328/4885PKM 1855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.